Omeros (OMER) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.40% |
| Dec 31, 2025 | 21.86% |
| Sep 30, 2025 | -51.52% |
| Jun 30, 2025 | 14.33% |
| Mar 31, 2025 | -26.57% |
| Dec 31, 2024 | 18.38% |
| Sep 30, 2024 | -16.25% |
| Jun 30, 2024 | 44.27% |
| Mar 31, 2024 | -23.89% |
| Dec 31, 2023 | -57.38% |
| Sep 30, 2023 | 202.28% |
| Jun 30, 2023 | 10.37% |
| Mar 31, 2023 | -26.63% |
| Dec 31, 2022 | -125.89% |
| Sep 30, 2022 | 125.01% |
| Jun 30, 2022 | 19.71% |
| Mar 31, 2022 | -149.92% |
| Dec 31, 2021 | 68.46% |
| Sep 30, 2021 | -23.95% |
| Jun 30, 2021 | 0.35% |
| Mar 31, 2021 | -30.65% |
| Dec 31, 2020 | -73.76% |
| Sep 30, 2020 | 63.69% |
| Jun 30, 2020 | -45.86% |
| Mar 31, 2020 | 29.99% |
| Dec 31, 2019 | -70.92% |
| Sep 30, 2019 | 52.42% |
| Jun 30, 2019 | -15.67% |
| Mar 31, 2019 | -17.21% |
| Dec 31, 2018 | 67.38% |
| Sep 30, 2018 | 29.87% |
| Jun 30, 2018 | 31.25% |
| Mar 31, 2018 | -55.96% |
| Dec 31, 2017 | 38.78% |
| Sep 30, 2017 | 17.59% |
| Jun 30, 2017 | 17.30% |
| Mar 31, 2017 | -15.70% |
| Dec 31, 2016 | -55.67% |
| Sep 30, 2016 | 50.92% |
| Jun 30, 2016 | 72.27% |
| Mar 31, 2016 | -21.08% |
| Dec 31, 2015 | 9.65% |
| Sep 30, 2015 | -91.05% |